-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA SUBMITS OPTIMIZED PHASE 2 STUDY PROTOCOL TO U.S. FDA FOR TEVERELIX IN ACUTE URINARY RETENTION

Reuters·04/06/2026 11:30:01

Please log in to view news